Evidence map›Paper›PMID 28356930›Full record

ArticleOncology letters2017

Effect of targeted silencing of IL-8 on

Yanyu Li, Ling Liu, Zeyuan Yin, Hui Xu, Shuang Li, Wei Tao, Hui Cheng, Lei Du, Xueyuan Zhou, Bei Zhang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yanyu LiDepartment of Gynaecology and Obstetrics, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China; Xuzhou Clinical School, Xuzhou Medical College, Xuzhou, Jiangsu 221000, P.R. China.
Ling LiuDepartment of Pharmacology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
Zeyuan YinXuzhou Clinical School, Xuzhou Medical College, Xuzhou, Jiangsu 221000, P.R. China.
Hui XuDepartment of Gynaecology and Obstetrics, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
Shuang LiDepartment of Gynaecology and Obstetrics, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
Wei TaoDepartment of Gynaecology and Obstetrics, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
Hui ChengDepartment of Gynaecology and Obstetrics, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
Lei DuJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou, Jiangsu 221000, P.R. China.
Xueyuan ZhouJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou, Jiangsu 221000, P.R. China.
Bei ZhangDepartment of Gynaecology and Obstetrics, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China; Xuzhou Clinical School, Xuzhou Medical College, Xuzhou, Jiangsu 221000, P.R. China.
Xuzhou Central Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to determine whether interleukin-8 (IL-8) affects human SKOV3 ovarian cancer cell migration and invasion by targeting silencing of IL-8 expression. Silencing small-interfering RNA (siRNA) targeting

Indexed as

cell invasioncell migrationinterleukin-8ovarian cancerp-nuclear factor-κB

Identifiers

PMID28356930
PMCPMC5351404
OpenAlexW2562265785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.